NCT07787663

Brief Summary

Physical inactivity is highly prevalent among older adults and is associated with declines in physical function, independence, quality of life, and social participation. The PACE tool provides 35 tailored physical activity programs for frail, community-dwelling older adults. Programs are prescribed by healthcare professionals using simple clinical criteria and can be delivered remotely. Previous research has demonstrated the feasibility, acceptability, safety, and effectiveness of adapted physical activity programs. The main objective of the project is to implement PACE in the geriatric outpatient clinics (CEG) of the Institut Universitaire de Gériatrie de Montréal (IUGM) to prevent deconditioning, promote autonomy, and reduce the burden on caregivers and healthcare resources.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
162

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 23, 2021

Completed
4.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 11, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 11, 2025

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

August 19, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 26, 2026

Completed
Last Updated

August 26, 2026

Status Verified

August 1, 2026

Enrollment Period

4.5 years

First QC Date

August 19, 2026

Last Update Submit

August 21, 2026

Conditions

Outcome Measures

Primary Outcomes (4)

  • Feasibility of the PACE tool

    will be measured using a score (expressed in % from 0 to 100) taking into account the ratio of the number of patients who have received a PA program prescription on the number of eligible patients.

    12 weeks

  • Adherence to the pace tool

    will be measured using a score (expressed in % from 0 to 100) taking into account the ratio of the number of completed sessions of PA on the prescribed sessions.

    12 weeks

  • Usability of the PACE TOOL

    Usability will be measured using the valided SUS questionnaire (10 items/score ranged from 0 to 100)

    12 weeks

  • Acceptability of the PACE Tool

    Will be evaluated by the administration of a questionnaire with 4 Likert level/question and each likert level expressed in % (from 0 to 100).

    12 weeks

Secondary Outcomes (3)

  • Changes in objective physical measures

    12 weeks

  • Changes in caregiver burden after intervention

    12 weeks

  • Changes in the quality of life after intervention (12-Item Short Form Survey: SF-12)

    12 weeks

Study Arms (2)

PACE Group

EXPERIMENTAL

Physical Activity program prescription via the PACE tool

Other: PACE

Control Group

NO INTERVENTION

Usual care

Interventions

PACEOTHER

The patient's mobility profile is determined using a decisional tree, which guides the prescription of an adapted physical activity (PA) program. The PACE tool includes 35 PA programs divided into 7 color-coded categories according to the physical components that should be prioritized (cardiorespiratory/muscular fitness, balance, and/or trunk mobility/stability). 5 difficulty levels provided. Each program includes 2 to 4 exercises (approx.15 min/day) and a walking goal ranging from 10 minutes (2 × 5 min) to 30 minutes (2 × 15 min). The program is prescribed daily for 12 weeks.

PACE Group

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • being followed in an outpatient geriatric clinic
  • Aged 60 years and older, with or without an informal caregiver
  • Have the cognitive capacity to provide informed consent;
  • Have no contraindications to physical activity;
  • Are not currently receiving rehabilitation services;
  • Are able to communicate, read, and understand French or English;

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UQAM

Montreal, Quebec, H3P 3C8, Canada

Location

MeSH Terms

Conditions

FrailtySarcopenia

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsMuscular AtrophyNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesAtrophyPathological Conditions, AnatomicalSigns and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principale Investigator-Researcher

Study Record Dates

First Submitted

August 19, 2026

First Posted

August 26, 2026

Study Start

March 23, 2021

Primary Completion

September 11, 2025

Study Completion

September 11, 2025

Last Updated

August 26, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will share

on demand only, without personal and sensitive data

Locations